193 related articles for article (PubMed ID: 19058310)
1. Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps.
Karaman A; Binici DN; Kabalar ME; Calikuşu Z
World J Gastroenterol; 2008 Nov; 14(44):6835-9. PubMed ID: 19058310
[TBL] [Abstract][Full Text] [Related]
2. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of serrated polyps.
Huang CS; Farraye FA; Yang S; O'Brien MJ
Am J Gastroenterol; 2011 Feb; 106(2):229-40; quiz 241. PubMed ID: 21045813
[TBL] [Abstract][Full Text] [Related]
4. Serrated polyps and colorectal cancer: new pathway to malignancy.
Noffsinger AE
Annu Rev Pathol; 2009; 4():343-64. PubMed ID: 19400693
[TBL] [Abstract][Full Text] [Related]
5. Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk.
Maffei F; Zolezzi Moraga JM; Angelini S; Zenesini C; Musti M; Festi D; Cantelli-Forti G; Hrelia P
Mutagenesis; 2014 May; 29(3):221-5. PubMed ID: 24668056
[TBL] [Abstract][Full Text] [Related]
6. Role of the serrated pathway in colorectal cancer pathogenesis.
Leggett B; Whitehall V
Gastroenterology; 2010 Jun; 138(6):2088-100. PubMed ID: 20420948
[TBL] [Abstract][Full Text] [Related]
7. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
[TBL] [Abstract][Full Text] [Related]
9. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
[TBL] [Abstract][Full Text] [Related]
10. Genomic instability and cellular stress in organ biopsies and peripheral blood lymphocytes from patients with colorectal cancer and predisposing pathologies.
Lombardi S; Fuoco I; di Fluri G; Costa F; Ricchiuti A; Biondi G; Nardini V; Scarpato R
Oncotarget; 2015 Jun; 6(17):14852-64. PubMed ID: 26046795
[TBL] [Abstract][Full Text] [Related]
11. [Serrated lesions and carcinoma of colorectum].
Lai MD
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):65-7. PubMed ID: 16630477
[No Abstract] [Full Text] [Related]
12. Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps.
Erichsen R; Baron JA; Hamilton-Dutoit SJ; Snover DC; Torlakovic EE; Pedersen L; Frøslev T; Vyberg M; Hamilton SR; Sørensen HT
Gastroenterology; 2016 Apr; 150(4):895-902.e5. PubMed ID: 26677986
[TBL] [Abstract][Full Text] [Related]
13. Colorectal serrated adenocarcinoma.
Mäkinen MJ
Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
[TBL] [Abstract][Full Text] [Related]
14. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
15. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
[TBL] [Abstract][Full Text] [Related]
16. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated DNA mutation detection in individuals undergoing colonoscopy.
Fleshner P; Braunstein GD; Ovsepyan G; Tonozzi TR; Kammesheidt A
Cancer Med; 2018 Jan; 7(1):167-174. PubMed ID: 29125240
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of colorectal cancer: Implications for cancer control.
Jass JR
Surg Oncol; 2007 Dec; 16 Suppl 1():S7-9. PubMed ID: 18023574
[TBL] [Abstract][Full Text] [Related]
19. [WHO classification 2010 for the lower gastrointestinal tract: what is new?].
Aust DE
Pathologe; 2011 Nov; 32 Suppl 2():326-31. PubMed ID: 21915662
[TBL] [Abstract][Full Text] [Related]
20. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.
Kurihara H; Maruyama R; Ishiguro K; Kanno S; Yamamoto I; Ishigami K; Mitsuhashi K; Igarashi H; Ito M; Tanuma T; Sukawa Y; Okita K; Hasegawa T; Imai K; Yamamoto H; Shinomura Y; Nosho K
Oncotarget; 2016 Mar; 7(11):12704-17. PubMed ID: 26871294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
